DENDRITIC CELL THERAPY RGCC
PUBLISHED FOR OPPOSITIONCombined Mark
Never miss important updates for DENDRITIC CELL THERAPY RGCC
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Key Information
Ownership
RH
Address
Baarerstrasse 95
CH
Critical Dates
First Use Date
Not filed yet
Filing Date
Sep 11, 2025
Publication Date
May 12, 2026
Mark Descriptions
Goods
Class 5
Class 005: Pharmaceutical products for the treatment of cancer; Pharmaceutical products for immune response modification; Medical preparations for the treatment of cancer; Medical preparations for immune response modification; Pharmaceutical products for modulating immune response; Medical preparations for modulating immune response...
Services
Class 42
Class 005: Pharmaceutical products for the treatment of cancer; Pharmaceutical products for immune response modification; Medical preparations for the treatment of cancer; Medical preparations for immune response modification; Pharmaceutical products for modulating immune response; Medical preparations for modulating immune response...
Class 44
Class 005: Pharmaceutical products for the treatment of cancer; Pharmaceutical products for immune response modification; Medical preparations for the treatment of cancer; Medical preparations for immune response modification; Pharmaceutical products for modulating immune response; Medical preparations for modulating immune response...
Mark Elements
Text Mark
DENDRITIC CELL THERAPY RGCC
Category
Trademark
Standard Characters
No
Color Claim
No
Trademark Timeline
Filing Date
Publication Date
USPTO Records
No documents found for this trademark.